- cafead May 07, 2023 at 10:22: PM
via Acelyrin went public Friday — and the biotech expects its upsized public offering to raise $540 million, the company announced.
The biopharma will now offer 30 million shares of common stock for $18 a share, and has given underwriters 30 days to buy up to 4.5 million more shares of common stock at the IPO price.
article source
The biopharma will now offer 30 million shares of common stock for $18 a share, and has given underwriters 30 days to buy up to 4.5 million more shares of common stock at the IPO price.
article source